ArticleLeukemia2022

Preemptive donor-derived anti-CD19 CAR T-cell infusion showed a promising anti-leukemia effect against relapse in MRD-positive B-ALL after allogeneic hematopoietic stem cell transplantation.

Xiang-Yu Zhao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.